TRICOL BIOMEDICAL, INC
Portland, OR · Medtech · Private
Hemostatic urinary catheter device (HUCD) with chitosan endoluminal hemostatic dressing for controlling post-operative bleeding in prostatic surgery
tricolbiomedical.com →- Grants
- $4.0M
- 6 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $6K
- 4 awards · Defense
- #637 of 4531 in medtech
- Patents
- 32
- 12 granted · 20 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20162017201820192020202120222023
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · Chitosan Endoluminal Hemostatic Dressing | $467,742 | |
| Federal contract | Department of Defense · 8505142910!BANDAGE,GAUZE,IMPRE | $1,225 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase II · Chitosan Gastrointestinal Hemostatic Dressing | $493,894 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase II · Chitosan Gastrointestinal Hemostatic Dressing | $919,507 | |
| Federal contract | Department of Defense · 8505540590!BANDAGE,GAUZE,IMPRE | $1,225 | |
| Federal grant | Department of Health and Human Services · Phase II · Chitosan Gastrointestinal Hemostatic Dressing | $425,613 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase II · Chitosan Endoluminal Hemostatic Dressing | $853,858 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase II · Chitosan Endoluminal Hemostatic Dressing | $853,858 | |
| Federal contract | Department of Defense · 8508828974!BANDAGE,GAUZE,IMPRE | $1,300 | |
| Federal contract | Department of Defense · 8509990212!BANDAGE,GAUZE,IMPRE | $1,800 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 634 | OSMIC ENTERPRISES, INC. | $9K | — |
| 635 | BIOVENTURES, INC | $7K | — |
| 636 | Biofrontera Inc. | $6K | $58M |
| 637 | TRICOL BIOMEDICAL, INC | $6K | — |
| 638 | Earlens Corp | $5K | $260M |
| 639 | ID GENOMICS SPC | $4K | $110K |
| 640 | Sofregen Medical Inc. | $4K | $14M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Chitosan Dressing For Control Of Gastrointestinal Bleedinggranted
- Tissue Adherent Chitosan Material That Resists Dissolutiongranted
- Chitosan Dressing For Control Of Bleeding In Transurethral Prostatectomygranted
- Dissolution Resistant Tissue Adherent Dressing Application And Its Deliveryapplication
- Chitosan Superfine Fiber Systemsapplication
- Chitosan Superfine Fiber Systemsgranted
- Chitosan Materials From Carbonic Acid Solutiongranted
- Biocompatible And Bioabsorbable Derivatized Chitosan Compositionsgranted
- Bioadhesive Chitosan Gel For Controlling Bleeding And For Promoting Healing With Scar Reduction Without Obscuring Or Interfering With Access To A Surgical Fieldgranted
- Biocompatible And Bioabsorbable Derivatized Chitosan Compositionsgranted
- Chitosan Materials From Carbonic Acid Solutiongranted
- Percutaneous Vascular Injury Treatment Systems And Methodsapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.